We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Supreme Court had taken an interest in a Justice Department whistleblower case over whether Gilead Sciences lied to the FDA about using an unapproved Chinese ingredient in some HIV drugs. But in an unexpected move